Search Results - "Mueller, Bruce A"

Therapeutic Monitoring of Vancomycin for Serious Methicillin-resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review by the American Society of Health-system Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists by Rybak, Michael J, Le, Jennifer, Lodise, Thomas P, Levine, Donald P, Bradley, John S, Liu, Catherine, Mueller, Bruce A, Pai, Manjunath P, Wong-Beringer, Annie, Rotschafer, John C, Rodvold, Keith A, Maples, Holly D, Lomaestro, Benjamin

“…Abstract Recent clinical data on vancomycin pharmacokinetics and pharmacodynamics suggest a reevaluation of current dosing and monitoring recommendations. The…”
Get full text

Antibiotic dosing recommendations in critically ill patients receiving new innovative kidney replacement therapy by Lewis, Susan J, Mueller, Bruce A

“…The Tablo Hemodialysis System is a new innovative kidney replacement therapy (KRT) providing a range of options for critically ill patients with acute kidney…”
Get full text

Executive Summary: Therapeutic Monitoring of Vancomycin for Serious Methicillin‐Resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review of the American Society of Health‐System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists by Rybak, Michael J., Le, Jennifer, Lodise, Thomas P., Levine, Donald P., Bradley, John S., Liu, Catherine, Mueller, Bruce A., Pai, Manjunath P., Wong‐Beringer, Annie, Rotschafer, John C., Rodvold, Keith A., Maples, Holly D., Lomaestro, Benjamin M.

“…Background Recent vancomycin PK/PD and toxicodynamic studies enable a reassessment of the current dosing and monitoring guideline in an attempt to further…”
Get full text

Vancomycin and daptomycin dosing recommendations in patients receiving home hemodialysis using Monte Carlo simulation by Lewis, Susan J, Jang, Soo Min, Mueller, Bruce A

“…Abstract Background Few drug dosing recommendations for patients receiving home hemodialysis (HHD) have been published which has hindered the adoption of HHD…”
Get full text

Ex vivo Rezafungin Adsorption and Clearance During Continuous Renal Replacement Therapy by Jang, Soo Min, Hough, Grayson, Mueller, Bruce A

“…To determine adsorption and transmembrane clearances (CLTM) of rezafungin, a novel long-acting echinocandin, in continuous venovenous hemofiltration (CVVH). A…”
Get more information

Medication Dosing in Critically Ill Patients With Acute Kidney Injury Treated With Renal Replacement Therapy by Scoville, Bridget A., PharmD, Mueller, Bruce A., PharmD

“…Critically ill patients with acute kidney injury may be treated with a variety of renal replacement therapies (RRTs). Each of these RRTs has profound yet…”
Get full text

Daptomycin pharmacokinetics in critically ill patients receiving continuous venovenous hemodialysis by Vilay, A. Mary, Grio, Maricor, DePestel, Daryl D, Sowinski, Kevin M, Gao, Lihong, Heung, Michael, Salama, Noha N, Mueller, Bruce A

“…OBJECTIVE:To investigate daptomycin pharmacokinetics in critically ill patients receiving continuous venovenous hemodialysis to develop dosing recommendations…”
Get full text

Development of a vancomycin dosing approach for critically ill patients receiving hybrid hemodialysis using Monte Carlo simulation by Lewis, Susan J, Mueller, Bruce A

“…Objectives: Prolonged intermittent renal replacement therapy is an increasingly popular treatment for acute kidney injury in critically ill patients that runs…”
Get full text

Pharmacokinetics of Ertapenem in Critically Ill Patients Receiving Continuous Venovenous Hemodialysis or Hemodiafiltration by EYLER, Rachel F, VILAY, A. Mary, NADER, Ahmed M, HEUNG, Michael, PLEVA, Melissa, SOWINSKI, Kevin M, DEPESTEL, Daryl D, SÖRGEL, Fritz, KINZIG, Martina, MUELLER, Bruce A

“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text

Size Matters: The Influence of Patient Size on Antibiotics Exposure Profiles in Critically Ill Patients on Continuous Renal Replacement Therapy by Jang, Soo-Min, Shaw, Alex R., Mueller, Bruce A.

“…(1) Purpose of this study: To determine whether patient weight influences the probability of target attainment (PTA) over 72 h of initial therapy with…”
Get full text

Imipenem/Relebactam Ex Vivo Clearance during Continuous Renal Replacement Therapy by Jang, Soo Min, Yessayan, Lenar, Dean, Michael, Costello, Gabrielle, Katwaru, Ravi, Mueller, Bruce A.

“…(1) Purpose of this study: determination of adsorption and transmembrane clearances (CLTM) of imipenem and relebactam in ex vivo continuous hemofiltration (CH)…”
Get full text

Intradialytic Oral Nutritional Supplements Improve Quality of Life by Vilay, A. Mary, PharmD, Mueller, Bruce A., PharmD

Get full text

Tedizolid Adsorption and Transmembrane Clearance during in vitro Continuous Renal Replacement Therapy by Lewis, Susan J, Switaj, Lynn A, Mueller, Bruce A

“…To study transmembrane clearance (CLTM) and adsorption of tedizolid, a novel oxazolidinone antibiotic, in continuous hemofiltration (CVVH) and continuous…”
Get more information

Clinical review: Drug metabolism and nonrenal clearance in acute kidney injury by Vilay, A Mary, Churchwell, Mariann D, Mueller, Bruce A

“…Decreased renal drug clearance is an obvious consequence of acute kidney injury (AKI). However, there is growing evidence to suggest that nonrenal drug…”
Get full text

Education Standards for Pharmacists Providing Comprehensive Medication Management in Outpatient Nephrology Settings by Hudson, Joanna Q., Maxson, Rebecca, Barreto, Erin F., Cho, Katherine, Condon, Amanda J., Goswami, Elizabeth, Moon, Jean, Mueller, Bruce A., Nolin, Thomas D., Nyman, Heather, Vilay, A. Mary, Meaney, Calvin J.

“…Chronic kidney disease is a public health problem that has generated renewed interest due to poor patient outcomes and high cost. The Advancing American Kidney…”
Get full text

Pharmacokinetics of Oseltamivir and Oseltamivir Carboxylate in Critically Ill Patients Receiving Continuous Venovenous Hemodialysis and/or Extracorporeal Membrane Oxygenation by Eyler, Rachel F., Heung, Michael, Pleva, Melissa, Sowinski, Kevin M., Park, Pauline K., Napolitano, Lena M., Mueller, Bruce A.

“…Study Objective To investigate oseltamivir and oseltamivir carboxylate pharmacokinetics in critically ill patients who were receiving continuous venovenous…”
Get full text

Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists by Rybak, Michael J, Le, Jennifer, Lodise, Thomas P, Levine, Donald P, Bradley, John S, Liu, Catherine, Mueller, Bruce A, Pai, Manjunath P, Wong-Beringer, Annie, Rotschafer, John C, Rodvold, Keith A, Maples, Holly D, Lomaestro, Benjamin M

Get full text

Single dose oral ranolazine pharmacokinetics in patients receiving maintenance hemodialysis by Scoville, Bridget A., Segal, Jonathan H., Salama, Noha N., Heung, Michael, Bleske, Barry E., Eyler, Rachel F., Mueller, Bruce A.

“…Purpose: Ranolazine is a novel anti-angina treatment approved in the United States for chronic stable angina. Ranolazine pharmacokinetics have not been studied…”
Get full text

Daptomycin Pharmacokinetics and Pharmacodynamics in a Pooled Sample of Patients Receiving Thrice-Weekly Hemodialysis by BUTTERED, Jill M, MUELLER, Bruce A, PATEL, Nimish, CARDONE, Katie E, GRABE, Darren W, SALAMA, Noha N, LODISE, Thomas P

“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text

Renal Dosing of Antibiotics: Are We Jumping the Gun? by Crass, Ryan L, Rodvold, Keith A, Mueller, Bruce A, Pai, Manjunath P

“…Abstract Antibiotic renal dose adjustments are determined in patients with stable chronic kidney disease and may not translate to patients in late-phase trials…”
Get full text